BioSpace News Archive

Lone Star Bio

Nanoscope Therapeutics to Present at the BIO International Convention

Nanoscope Therapeutics Inc. today announced that management will present at the BIO International Convention, taking place June 5-8, 2023, in Boston, MA.

June 5, 2023
·
2 min read
Business

Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate Update

Chemomab Therapeutics Ltd. (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced changes to its executive leadership team and provided a corporate update.

June 5, 2023
·
7 min read
Bio NC

Precision BioSciences to Present at Upcoming June Investor Conferences

Precision BioSciences, Inc. today announced that members of management will participate in the following investor conferences in June 2023.

June 5, 2023
·
1 min read
Business

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting - June 5, 2023

MiNK Therapeutics today announced that its virtual-only Annual Meeting of Shareholders will be held on Tuesday, June 13, 2023, at 10:30 AM ET.

June 5, 2023
·
1 min read
Pharm Country

TG Therapeutics to Participate in the 2023 Jefferies Healthcare ConferenceFireside chat scheduled for Wednesday, June 7, 2023, at 11:30 AM ET

TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the 2023 Jefferies Healthcare Conference, being held at the Marriott Marquis Hotel, in New York City on June 7th – 9th , 2023.

June 5, 2023
·
1 min read
Deals

Aptose Biosciences Provides Update on Reverse Stock Split

Aptose Biosciences Inc. announced today that the Company effected a reverse stock split on May 24, 2023 at a ratio of 15-to-1 (the “Reverse Stock Split”).

June 5, 2023
·
4 min read
Genetown

Agenus Announces Virtual Annual Shareholders Meeting - June 5, 2023

Agenus today announced that its Annual Shareholders Meeting will begin at 10:30 a.m. ET on June 12, 2023 and will be conducted in a virtual format only.

June 5, 2023
·
1 min read
Business

Cybin Announces Scientific Management Transition Following Achievement of Final Adelia Milestones

Michael Palfreyman Ph.D. and Brett Greene, who joined Cybin as part of the acquisition of Adelia Therapeutics, move into advisory roles.

June 5, 2023
·
7 min read
Bio NC

KBI Biopharma Unveils KBI PUREplatform™, a Game-Changing Microbial Expression Offering to Redefine Biopharmaceutical Manufacturing

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of KBI PUREplatform™, a premium microbial cell line development (CLD) platform that features unmatched efficiencies in a microbial expression system for biopharmaceutical production.

June 5, 2023
·
3 min read
Drug Development

Walden Biosciences Announces First Subject Dosed in First-in-Humans Phase 1 Clinical Trial of WAL0921, in Development for Treatment of Chronic Kidney Diseases

Walden Biosciences, Inc. today announced that the first subject was dosed in the Company’s Phase 1 clinical trial of WAL0921 in healthy subjects.

June 5, 2023
·
3 min read